Keith Matthews Selected Research

Keith Matthews Research Topics

5	Treatment-Resistant Depressive Disorder 10/2022 - 09/2003
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 05/2015
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015 - 11/2006
4	Major Depressive Disorder (Major Depressive Disorders) 01/2014 - 06/2010
3	Opioid-Related Disorders (Opiate Addiction) 04/2022 - 02/2018
3	Chronic Pain 04/2022 - 12/2018
2	Pain (Aches) 04/2022 - 12/2018
2	Mental Disorders (Mental Disorder) 01/2019 - 09/2014
1	Substance-Related Disorders (Drug Abuse) 04/2022
1	Epilepsy (Aura) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Mood Disorders (Mood Disorder) 09/2013
1	Infections 08/2004

3	Opioid Analgesics (Opioids)IBA 04/2022 - 12/2018
3	Methylphenidate (Ritalin)FDA LinkGeneric 01/2015 - 11/2006
2	CannabinoidsIBA 04/2022 - 12/2018
2	Capsules (Microcapsules)IBA 01/2022 - 01/2019
2	Methadone (Dolophine)FDA LinkGeneric 12/2018 - 02/2018
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 05/2012
1	Analgesics (Analgesic Drugs)IBA 04/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	Antimanic AgentsIBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	BenzodiazepinesIBA 12/2018
1	Heroin (Diamorphine)IBA 02/2018
1	Antidepressive Agents (Antidepressants)IBA 11/2017
1	salicylhydroxamic acid (SHAM)IBA 11/2017
1	CatecholaminesIBA 10/2014
1	Complementary DNA (cDNA)IBA 01/2014
1	CytokinesIBA 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 08/2004

5	Vagus Nerve Stimulation 01/2015 - 09/2003
4	Deep Brain Stimulation 01/2022 - 11/2017
4	Therapeutics 01/2021 - 06/2010
1	Radiofrequency Ablation 10/2022
1	Opiate Substitution Treatment 01/2021
1	Drug Therapy (Chemotherapy) 05/2015
1	Neurosurgical Procedures 09/2014